M Pergande

939 total citations
30 papers, 739 citations indexed

About

M Pergande is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Nephrology. According to data from OpenAlex, M Pergande has authored 30 papers receiving a total of 739 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Molecular Biology and 7 papers in Nephrology. Recurrent topics in M Pergande's work include Alkaline Phosphatase Research Studies (7 papers), Metabolism and Genetic Disorders (5 papers) and Chronic Kidney Disease and Diabetes (5 papers). M Pergande is often cited by papers focused on Alkaline Phosphatase Research Studies (7 papers), Metabolism and Genetic Disorders (5 papers) and Chronic Kidney Disease and Diabetes (5 papers). M Pergande collaborates with scholars based in Germany, United States and Belgium. M Pergande's co-authors include Klaus Jung, T Porstmann, L. M. Fels, Hilmar Stolte, H.-J. Graubaum, G Schreiber, Karsten Schröder, Roland Grunow, R. von Baehr and Silke Klotzek and has published in prestigious journals such as FEBS Letters, Clinical Chemistry and Clinica Chimica Acta.

In The Last Decade

M Pergande

28 papers receiving 701 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Pergande Germany 14 174 172 116 87 77 30 739
M. Cochran Australia 18 171 1.0× 123 0.7× 85 0.7× 43 0.5× 27 0.4× 44 805
Barry B. Kirschbaum United States 16 267 1.5× 169 1.0× 69 0.6× 23 0.3× 18 0.2× 63 704
Richard Bourbouze France 17 219 1.3× 240 1.4× 19 0.2× 34 0.4× 60 0.8× 52 887
De Broe Me Belgium 12 125 0.7× 148 0.9× 55 0.5× 15 0.2× 30 0.4× 30 611
Roxana Popescu Romania 16 134 0.8× 177 1.0× 37 0.3× 56 0.6× 45 0.6× 92 751
R. A. J. Conyers Australia 12 26 0.1× 194 1.1× 43 0.4× 65 0.7× 120 1.6× 32 803
Anita C. A. Dankers Netherlands 11 104 0.6× 264 1.5× 81 0.7× 252 2.9× 30 0.4× 12 1.0k
J Pybus New Zealand 13 66 0.4× 111 0.6× 85 0.7× 21 0.2× 74 1.0× 25 918
H. Rothe Germany 24 224 1.3× 304 1.8× 172 1.5× 19 0.2× 211 2.7× 49 1.6k
Sándor Túri Hungary 18 156 0.9× 299 1.7× 14 0.1× 40 0.5× 67 0.9× 56 1.1k

Countries citing papers authored by M Pergande

Since Specialization
Citations

This map shows the geographic impact of M Pergande's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Pergande with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Pergande more than expected).

Fields of papers citing papers by M Pergande

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Pergande. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Pergande. The network helps show where M Pergande may publish in the future.

Co-authorship network of co-authors of M Pergande

This figure shows the co-authorship network connecting the top 25 collaborators of M Pergande. A scholar is included among the top collaborators of M Pergande based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Pergande. M Pergande is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fels, L. M., M Pergande, Klaus Jung, et al.. (1994). Nephron target sites in chronic exposure to lead. Nephrology Dialysis Transplantation. 9(12). 1740–1746. 12 indexed citations
2.
Gwinner, Wilfried, et al.. (1994). Early urinary markers of target nephron segments as studied in cadmium toxicity.. PubMed. 47. S81–8. 24 indexed citations
3.
Pergande, M, et al.. (1994). Changed excretion of urinary proteins and enzymes by chronic exposure to lead. Nephrology Dialysis Transplantation. 9(6). 613–618. 30 indexed citations
4.
Jung, Klaus, M Pergande, Friedrich Priem, Jonathan Becker, & Silke Klotzek. (1993). Rapid Screening of Low Molecular Mass Proteinuria: Evaluation of the First Immunochemical Test Strip for the Detection of α1-Microglobulin in Urine. Clinical Chemistry and Laboratory Medicine (CCLM). 31(10). 683–7. 3 indexed citations
5.
Jung, Klaus, et al.. (1993). Urinary proteins and enzymes as early indicators of renal dysfunction in chronic exposure to cadmium. Clinical Chemistry. 39(5). 757–765. 46 indexed citations
6.
Jung, Klaus, et al.. (1990). A microalbuminuria assay using bromphenol blue. Clinica Chimica Acta. 187(2). 163–172. 17 indexed citations
8.
Jung, Klaus, et al.. (1989). Measurement of lysozyme in human body fluids: Comparison of various enzyme immunoassay techniques and their diagnostic application. Clinical Biochemistry. 22(5). 349–355. 133 indexed citations
9.
Jung, Klaus, et al.. (1989). Further evidence for tubular dysfunction in insulin dependent diabetes. Journal of Diabetic Complications. 3(3). 167–171. 7 indexed citations
10.
Jung, Klaus, et al.. (1989). [Urine enzymes and low molecular weight proteins as indicators of diabetic nephropathy].. PubMed. 67 Suppl 17. 27–30. 3 indexed citations
11.
Jung, Klaus, M Pergande, & Silke Klotzek. (1989). Sialidase from different sources compared for electrophoretically separating serum alkaline phosphatase fractions from liver and bone.. Clinical Chemistry. 35(9). 1955–1957. 10 indexed citations
12.
Jung, Klaus, et al.. (1988). Diuresis-dependent excretions of low-molecular mass proteins in urine: β2-microglobulin, lysozyme, and ribonuclease. Scandinavian Journal of Clinical and Laboratory Investigation. 48(1). 33–37. 8 indexed citations
13.
Porstmann, T, et al.. (1988). A rapid and sensitive enzyme immunoassay for Cu/Zn Superoxide dismutase with polyclonal and monoclonal antibodies. Clinica Chimica Acta. 171(1). 1–10. 40 indexed citations
14.
Jung, Klaus, et al.. (1988). Urinary enzymes and low-molecular-mass proteins as indicators of diabetic nephropathy.. Clinical Chemistry. 34(3). 544–547. 55 indexed citations
15.
Jung, Klaus, et al.. (1987). Diagnostic Value of Low-Molecular Mass Proteins in Serum for the Detection of Reduced Glomerular Filtration Rate. Clinical Chemistry and Laboratory Medicine (CCLM). 25(8). 499–503. 21 indexed citations
17.
Jung, Klaus, M Pergande, G Schreiber, & Karsten Schröder. (1983). Stability of enzymes in urine at 37°C. Clinica Chimica Acta. 131(3). 185–191. 23 indexed citations
18.
Jung, Klaus, et al.. (1979). Suitability of commercial control sera for the quality control of activity determination of alkaline phosphatase. Clinica Chimica Acta. 97(2-3). 171–178. 3 indexed citations
19.
Jung, Klaus, et al.. (1979). Stability of Isoenzymes of Alkaline Phosphatase in VariousBuffer Systems. Enzyme. 24(1). 18–22. 2 indexed citations
20.
Jung, Klaus & M Pergande. (1979). Influence of Mg^2+ Ions on the Activity Measurement ofIsoenzymes of Alkaline Phosphatase. Enzyme. 24(5). 322–326. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026